Cowdy Philip G. 4/A

What Happened
Philip G. Cowdy, a director of Bioventus Inc. (BVS), was originally reported as receiving an award of 9,000 restricted stock units (derivative securities) on February 11, 2021 (transaction code A) at $0 per share. The Form 4 was amended on April 14, 2026 to correct an earlier, inadvertent filing: the award was not accepted by Cowdy and, as of February 11, 2021, he held no derivative or non‑derivative securities of the issuer. The reported grant therefore carries no purchase price or realized value.

Key Details

• Transaction date: February 11, 2021 (reported originally Feb 16, 2021 in error; amended Apr 14, 2026).
• Transaction type/code: Award/Grant (A) of 9,000 restricted stock units; reported price $0.00.
• Shares owned after transaction: 0 non‑derivative and 0 derivative securities (per amended filing).
• Footnotes: F1 states the original Form 4 mistakenly reported an RSU grant that was not accepted; F2: none.
• Timeliness: This is an amended filing submitted years after the original report to correct the record.

Context
Restricted stock units (RSUs) are derivative awards that convert to shares if accepted/vested; because Cowdy did not accept the award, there was no acquisition and no change in his holdings. This amendment corrects the public filing and does not indicate insider buying, selling, or a change in ownership.